MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...

New start-up Uniquity Bio arrived on the scene today with $300 million in funding from Blackstone Life Sciences and a clinical-stage inflammation and immunology drug licensed from MSD. The FDA has ...

Endries International, Brillion, WI, a distributor of fasteners and related production components, has announced that MSD Partners, L.P., along with Endries management, has acquired Endries from ...

In this episode of New Zealand Channel Voices, Reseller News speaks with Rana Stephan, winner of the 2024 Women in ICT Achievement Award, about her 30-year journey in the technology sector and the key ...